Compromise by Bush reinforces stem cell research ambiguity

President Bush surprised the US last week by announcing a policy on embryonic stem cells research that will satisfy neither proponents or opponents of such work.

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Arguing that private research has produced more than 60 genetically diverse stem cell colonies, or lines, that could reproduce themselves indefinitely, Bush said in a nationalized TV address, "I have concluded that we should allow federal funds to be used for research on these existing stem cell lines, where the life and death decision has already been made."

He added that the research would be limited to cells that had already been extracted, and that the government would not support the destruction of new embryos. As a result, research on stem cells extracted from spare embryos left over after in vitro fertilization cannot go ahead if it uses federal funds.

Proponents of embryonic stem cells research criticized Bush for closing the door on obtaining stem cells from embryos that have been created for in vitro fertilization but are not being used by couples. "There will be concern about the limits ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Scott Gotlieb

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours